SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD.

Highlights Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460 BMG8162K1137

Market Closed - Hong Kong S.E. Other stock markets 04:08:25 2024-05-27 am EDT			5-day change	1st Jan Change
0.57 ^HKD	0.00%		-6.56%	-12.31%

May. 27	Sihuan Pharmaceutical, Unit Withdraw Latter's Stock Exchange Bid, Shares Down by Over 3%	MT
May. 02	Sihuan Pharmaceutical Unit's Lung Cancer Drug NDA Accepted by NMPA, Stocks Shoot Over 10%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sihuan Pharmaceutical, Unit Withdraw Latter's Stock Exchange Bid, Shares Down by Over 3%	May. 27	MT
Sihuan Pharmaceutical Unit's Lung Cancer Drug NDA Accepted by NMPA, Stocks Shoot Over 10%	May. 02	MT
Sihuan Pharma Unit Wins Bid to Supply Insulin Products to Chinese Government	Apr. 25	MT
Sihuan Pharmaceutical Narrows 2023 Loss on Absence of Asset, Investment Impairments	Mar. 29	MT
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Sihuan Pharmaceutical's RF Device Wins Registration Approval in China	Mar. 25	MT
China Approves Drug Registration for Sihuan Pharmaceutical Unit's Type 2 Diabetes Drug	Jan. 22	MT
Sihuan Pharmaceutical Holdings Group Ltd. Receives Registration Approval from National Medical Products Administration for Proline Janagliflozin Tablets	Jan. 22	CI
China Includes Four Injectables by Sihuan Pharma Associate in Drug Reimbursement List; Shares Rise 3%	Jan. 10	MT
Sihuan Pharmaceutical Holdings Group Ltd. Obtains Drug Registration Approval from the National Medical Products Administration of the People's Republic of China for the Treatment of Diabetes	Jan. 07	CI
China's Medical Products Administrator Approves Sihuan Pharma Unit's Diabetes Drug	23-10-24	MT
National Medical Products Administration Approves IND Application of Insulin Degludec and Liraglutide Injection, Developed by Huisheng Biopharmaceutical	23-10-24	CI
China Accepts New Drug Application of Sihuan Pharmaceutical Subsidiary's Breast Cancer Treatment	23-10-16	MT
China Accepts New Drug Application for Sihuan Pharmaceutical Unit's Breast Cancer Tablets	23-09-04	MT
Sihuan Pharmaceutical Swings to H1 Loss	23-08-29	MT
Sihuan Pharmaceutical Holdings Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Sihuan Pharmaceutical's Revenue to Drop 30% in H1	23-08-03	MT
Sihuan Pharmaceutical Holdings Group Ltd. Provides Unaudited Consolidated Guidance for the Six Months Ended 30 June 2023	23-08-02	CI
Sihuan Pharma Unit Gets Nod to Test Diabetes Drug	23-07-04	MT
Sihuan Pharmaceutical Holdings Group Ltd. Announces Huisheng Biopharmaceutical's Drug Semaglutide Injection Obtained Approval for Clinical Trial	23-07-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sihuan Pharmaceutical Holdings Group Ltd.

Equities

460

BMG8162K1137

Highlights

Filters